Published in Neuropathol Appl Neurobiol on April 01, 2005
In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage (2007) 1.41
Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis. Neurobiol Aging (2007) 1.22
Olfactory discrimination predicts cognitive decline among community-dwelling older adults. Transl Psychiatry (2012) 0.84
Clusters of secretagogin-expressing neurons in the aged human olfactory tract lack terminal differentiation. Proc Natl Acad Sci U S A (2012) 0.81
Neurogenesis, Neurodegeneration, Interneuron Vulnerability, and Amyloid-β in the Olfactory Bulb of APP/PS1 Mouse Model of Alzheimer's Disease. Front Neurosci (2016) 0.75
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology (2012) 2.23
The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease. Neuropathol Appl Neurobiol (2008) 1.58
Neuropathological evaluation of mixed dementia. J Neurol Sci (2007) 1.51
Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol (2006) 1.30
Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. Eur J Neurol (2007) 1.05
Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7. Clin Neuropathol (2010) 0.99
Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism. Acta Neurol Scand (2006) 0.94
Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. Br J Cancer (2003) 0.89
Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer (2007) 0.89
Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter. Neuropathol Appl Neurobiol (2013) 0.82
Cerebral amyloid angiopathy in Lewy body disease. J Neural Transm (Vienna) (2008) 0.81
Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment. Curr Alzheimer Res (2009) 0.77
Lung disease 35 years after aspiration of activated charcoal in combination with pulmonary lymphangioleiomyomatosis. A histological and clinicopathological study with scanning electron microscopic evaluation and element analysis. Virchows Arch (2006) 0.75